These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 12107549

  • 1. Influence of chemosensitizers on resistance mechanisms in daunorubicin-resistant Ehrlich ascites tumour cells.
    Nielsen D, Eriksen J, Maare C, Friche E, Skovsgaard T.
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):453-60. PubMed ID: 12107549
    [Abstract] [Full Text] [Related]

  • 2. Expression of P-glycoprotein and multidrug resistance associated protein in Ehrlich ascites tumor cells after fractionated irradiation.
    Nielsen D, Maare C, Eriksen J, Litman T, Skovsgaard T.
    Int J Radiat Oncol Biol Phys; 2001 Nov 15; 51(4):1050-7. PubMed ID: 11704330
    [Abstract] [Full Text] [Related]

  • 3. Characterisation of multidrug-resistant Ehrlich ascites tumour cells selected in vivo for resistance to etoposide.
    Nielsen D, Maare C, Eriksen J, Litman T, Friche E, Skovsgaard T.
    Biochem Pharmacol; 2000 Aug 01; 60(3):353-61. PubMed ID: 10856430
    [Abstract] [Full Text] [Related]

  • 4. Characterisation of non-P-glycoprotein multidrug-resistant Ehrlich ascites tumour cells selected for resistance to mitoxantrone.
    Nielsen D, Eriksen J, Maare C, Litman T, Kjaersgaard E, Plesner T, Friche E, Skovsgaard T.
    Biochem Pharmacol; 2000 Aug 01; 60(3):363-70. PubMed ID: 10856431
    [Abstract] [Full Text] [Related]

  • 5. Kinetics of daunorubicin transport in Ehrlich ascites tumor cells with different expression of P-glycoprotein.
    Nielsen D, Maare C, Skovsgaard T.
    Biochem Pharmacol; 1994 Jun 15; 47(12):2125-35. PubMed ID: 7913318
    [Abstract] [Full Text] [Related]

  • 6. Influx of daunorubicin in multidrug resistant Ehrlich ascites tumour cells: correlation to expression of P-glycoprotein and efflux. Influence of verapamil.
    Nielsen D, Maare C, Skovsgaard T.
    Biochem Pharmacol; 1995 Aug 08; 50(4):443-50. PubMed ID: 7646548
    [Abstract] [Full Text] [Related]

  • 7. Characterization of tumor cell resistance to 4'-deoxy-4'-iododoxorubicin developed in Ehrlich ascites cells in vivo.
    Friche E, Danks MK, Beck WT.
    Cancer Res; 1992 Oct 15; 52(20):5701-6. PubMed ID: 1356619
    [Abstract] [Full Text] [Related]

  • 8. The solvents cremophor EL and Tween 80 modulate daunorubicin resistance in the multidrug resistant Ehrlich ascites tumor.
    Friche E, Jensen PB, Sehested M, Demant EJ, Nissen NN.
    Cancer Commun; 1990 Oct 15; 2(9):297-303. PubMed ID: 1976341
    [Abstract] [Full Text] [Related]

  • 9. Cytosolic free Ca2+ in daunorubicin and vincristine resistant Ehrlich ascites tumor cells. Drug accumulation is independent of intracellular Ca2+ changes.
    Bouchelouche P, Friche E, Sehested M, Jensen PB, Skovsgaard T.
    Biochem Pharmacol; 1991 Jan 15; 41(2):243-53. PubMed ID: 1899193
    [Abstract] [Full Text] [Related]

  • 10. Transport of the multidrug resistance modulators verapamil and azidopine in wild type and daunorubicin resistant Ehrlich ascites tumour cells.
    Sehested M, Skovsgaard T, Jensen PB, Demant EJ, Friche E, Bindslev N.
    Br J Cancer; 1990 Jul 15; 62(1):37-41. PubMed ID: 1975202
    [Abstract] [Full Text] [Related]

  • 11. Daunorubicin and vincristine binding to plasma membrane vesicles from daunorubicin-resistant and wild type Ehrlich ascites tumor cells.
    Sehested M, Bindslev N, Demant EJ, Skovsgaard T, Jensen PB.
    Biochem Pharmacol; 1989 Sep 15; 38(18):3017-27. PubMed ID: 2571333
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of cyclosporin A and SDZ PSC833 as multidrug-resistance modulators in a daunorubicin-resistant Ehrlich ascites tumor.
    Friche E, Jensen PB, Nissen NI.
    Cancer Chemother Pharmacol; 1992 Sep 15; 30(3):235-7. PubMed ID: 1628375
    [Abstract] [Full Text] [Related]

  • 15. Influence of the fluoroquinolone ofloxacin on the intrinsic expression of multidrug resistance phenotype in HCT-8 human colon carcinoma cells.
    Marchal S, Merlin JL, Colosetti P, Finance C.
    Oncol Res; 1999 Sep 15; 11(8):375-81. PubMed ID: 10803741
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.
    Stein U, Lage H, Jordan A, Walther W, Bates SE, Litman T, Hohenberger P, Dietel M.
    Int J Cancer; 2002 Feb 20; 97(6):751-60. PubMed ID: 11857350
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.